Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Diagnostic criteria
Overview
This microlearning reviews myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, with a focus on the 2023 International MOGAD Panel diagnostic criteria. This lesson explains how the clinical presentation, MOG-IgG result, supporting features, and exclusion of alternative diagnoses work together.
Learning objectives
- Identify the three required components of the MOGAD diagnostic criteria.
- Describe where MOGAD fits among CNS demyelinating diseases.
- Explain the purpose of MOG-IgG testing.
- Recognize supporting MRI and clinical features.
- Identify findings that suggest an alternative diagnosis.
Intended audience
This activity is intended for neurologists, neuroimmunologists, neuro-ophthalmologists, neurology residents and fellows, advanced practice providers, and laboratory professionals involved in the evaluation and diagnosis of patients with suspected central nervous system demyelinating disorders.
Questions?
Contact us: mcleducation@mayo.edu
